Andrew Fontenot is a Rheumatology/Immunology physician affiliated with Regeneron. OpenAlex indexes 175 publications with 7,934 citations (h-index 49). By OpenAlex citation count, this profile ranks in the top 10% of Allergy & Immunology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Provider last certified this registry record 16 Apr 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20223 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Corticosteroid100%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
13 NIH research awards on record, funded 1998–2021 per NIH RePORTER. The latest:
- Role of Chemokines in Innate and Adaptive Immunity in the Lung
University of Colorado Denver
FY2021$602,292R01HL152756 - Role of Chemokines in Innate and Adaptive Immunity in the Lung
University of Colorado Denver
FY2020$619,277R01HL152756
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CD4+ T cells in the lungs of acute sarcoidosis patients recognize an <i>Aspergillus nidulans</i> epitope
The Journal of Experimental Medicine
2021 - Genetic, Immunologic, and Environmental Basis of Sarcoidosis
Annals of the American Thoracic Society
2017 - Interplay of innate and adaptive immunity in metal-induced hypersensitivity
Current Opinion in Immunology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Kimberly
Regeneron
Robert Vitti, MD
Regeneron
Thomas Uldrick, MD
Regeneron
Mihaela Cristea, MD
Regeneron
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”